- Global Pharma News & Resources

Press Releases - 2022-08-29

Date Title Company
29-Aug-2022 Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures Vita 34 AG
29-Aug-2022 Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022 Avance Clinical
29-Aug-2022 Blood Screening And Typing Market Business Growth, Analysis, Demand, Future Forecast 2030 healthcarereportsmarkets
29-Aug-2022 NGS Sample Preparation Market is forecasted to be appraised at US$ 5441.1 million by 2032 MARKITWIRED
29-Aug-2022 Cancer Gene Therapy Market size reaching US$ 5.3 Billion in 2032 MARKITWIRED
29-Aug-2022 Digital Patient Monitoring Systems Market is expected to reach a valuation of US$ 470 Billion by 2032 MARKITWIRED
29-Aug-2022 Varicella Vaccines Market is expected to grow at a CAGR of 6.3% from 2022 to 2032 MARKITWIRED
29-Aug-2022 Veterinary Services Market is projected to expand at a CAGR of around 8% during 2022 – 2032 | FMI MARKITWIRED
29-Aug-2022 Epiglottitis Treatment Market Analysis, Recent Trends and Regional Growth Forecast by 2032 MARKITWIRED
29-Aug-2022 IVD Antibodies Market Industry Analysis, Future Trends, Opportunity Growth, Regional Outlook and Forecast 2028 MARKITWIRED
29-Aug-2022 Weight Management Market is expected to garner US$ 725.6 Billion during the forecast period from 2022 to 2032 MARKITWIRED
29-Aug-2022 Hemostatic Gels Market to Grow at a 6.8% CAGR through 2032 MARKITWIRED
29-Aug-2022 HIV Antivirals Market is set to reach a valuation of US$ 30.6 Billion in 2022 MARKITWIRED
29-Aug-2022 Uni-Bio Science Group Limited: 2022 Interim Results UNI-BIO SCIENCE GROUP LIMITED
29-Aug-2022 Latest simulation analyses from the SANTORINI registry indicates that adding bempedoic acid in the lipid lowering treatment algorithm might help more patients achieve LDL-C recommended goals Daiichi Sankyo Europe
29-Aug-2022 New data further strengthens important role of LIXIANA® (edoxaban) in managing complex patient populations with atrial fibrillation (AF) Daiichi Sankyo Europe
29-Aug-2022 Moderna, Inc.: Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214 Moderna, Inc.
29-Aug-2022 Neuroendocrine Carcinoma Market Size, Top Leading Manufacturers with Share 2029 MARKITWIRED
29-Aug-2022 Human Identification Market Opportunities and Challenges, Growth by 2029 MARKITWIRED